Please Wait
Applying Filters...
menu
    • menu
    European CDMO and Gx manufacturer with 75 years of experience in delivering premium APIs to pharmaceutical partners worldwide.

    Virtual Booth

    Contact Supplier

    Veranova: A CDMO that manages complexity with confidence.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    An Enquiry

    Gangwal Healthcare is powered by innovation, driving health, wellness & healing.

    Virtual Booth

    Contact Supplier

    Aspen API. More than just an API™

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    An Enquiry

    Menu

    Soquelitinib

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Corvus Pharma Investor Meeting To Showcase Soquelitinib Data
    Corvus Pharma Investor Meeting To Showcase Soquelitinib Data

    21 Apr 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/04/21/3277804/0/en/corvus-pharmaceuticals-to-host-investor-and-analyst-meeting-on-may-14-2026-to-highlight-soquelitinib-data-being-presented-at-the-society-for-investigative-dermatology-sid-annual-me.html

    GLOBENEWSWIRE
    21 Apr 2026
    Share Share
    Corvus Pharma Updates Business And Releases 2025 Financials
    Corvus Pharma Updates Business And Releases 2025 Financials

    12 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/12/3255077/0/en/Corvus-Pharmaceuticals-Provides-Business-Update-and-Reports-Fourth-Quarter-and-Full-Year-2025-Financial-Results.html

    GLOBENEWSWIRE
    12 Mar 2026
    Share Share
    Corvus Pharma Confirms Positive Phase 1 Trial Data
    Corvus Pharma Confirms Positive Phase 1 Trial Data

    20 Jan 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/01/20/3221554/0/en/Corvus-Pharmaceuticals-Announces-Positive-Data-from-Cohort-4-Confirming-Results-for-Placebo-Controlled-Phase-1-Clinical-Trial-of-Soquelitinib-for-Atopic-Dermatitis.html

    GLOBENEWSWIRE
    20 Jan 2026
    Share Share
    Corvus Pharma To Report Cohort 4 Results Of Soquelitinib Trial
    Corvus Pharma To Report Cohort 4 Results Of Soquelitinib Trial

    16 Jan 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/01/16/3220545/0/en/Corvus-Pharmaceuticals-to-Announce-Results-from-Cohort-4-of-Placebo-Controlled-Phase-1-Clinical-Trial-of-Soquelitinib-for-Atopic-Dermatitis.html

    GLOBENEWSWIRE
    16 Jan 2026
    Share Share
    Corvus Pharma To Release Cohort 4 Results Of Soquelitinib Trial
    Corvus Pharma To Release Cohort 4 Results Of Soquelitinib Trial

    05 Jan 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/01/05/3212781/0/en/Corvus-Pharmaceuticals-Confirms-Plans-to-Announce-Results-from-Cohort-4-of-Placebo-Controlled-Phase-1-Clinical-Trial-of-Soquelitinib-for-Atopic-Dermatitis-in-January-2026-Following.html

    GLOBENEWSWIRE
    05 Jan 2026
    Share Share
    Corvus Pharma Unveils P1/1b Soquelitinib Data in T-Cell Lymphoma
    Corvus Pharma Unveils P1/1b Soquelitinib Data in T-Cell Lymphoma

    08 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/08/3201702/0/en/Corvus-Pharmaceuticals-Presents-Final-Data-from-Soquelitinib-Phase-1-1b-T-Cell-Lymphoma-Trial.html

    GLOBENEWSWIRE
    08 Dec 2025
    Share Share
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.